JP2023533162A5 - - Google Patents
Info
- Publication number
- JP2023533162A5 JP2023533162A5 JP2022575231A JP2022575231A JP2023533162A5 JP 2023533162 A5 JP2023533162 A5 JP 2023533162A5 JP 2022575231 A JP2022575231 A JP 2022575231A JP 2022575231 A JP2022575231 A JP 2022575231A JP 2023533162 A5 JP2023533162 A5 JP 2023533162A5
- Authority
- JP
- Japan
- Prior art keywords
- ksp37
- protein
- subject
- viral
- genetically engineered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA2020/04008 | 2020-07-09 | ||
| ZA2020/03850 | 2020-07-09 | ||
| ZA202003850 | 2020-07-09 | ||
| ZA202004008 | 2020-07-09 | ||
| PCT/IB2021/056179 WO2022009165A1 (en) | 2020-07-09 | 2021-07-09 | Compositions and methods useful for the prevention and/or treatment of disease in mammals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023533162A JP2023533162A (ja) | 2023-08-02 |
| JP2023533162A5 true JP2023533162A5 (https=) | 2024-01-19 |
Family
ID=79552952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575231A Pending JP2023533162A (ja) | 2020-07-09 | 2021-07-09 | 哺乳動物における疾患の予防及び／又は治療に有用な組成物及び方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240091310A1 (https=) |
| EP (1) | EP4178604A4 (https=) |
| JP (1) | JP2023533162A (https=) |
| KR (1) | KR20230038230A (https=) |
| CN (1) | CN115720520A (https=) |
| AU (1) | AU2021304479A1 (https=) |
| BR (1) | BR112022026874A2 (https=) |
| CA (1) | CA3179965A1 (https=) |
| CL (1) | CL2023000073A1 (https=) |
| CO (1) | CO2022019251A2 (https=) |
| IL (1) | IL299661A (https=) |
| MX (1) | MX2023000113A (https=) |
| PE (1) | PE20231554A1 (https=) |
| PH (1) | PH12023550038A1 (https=) |
| WO (1) | WO2022009165A1 (https=) |
| ZA (1) | ZA202213371B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025215561A1 (en) * | 2024-04-09 | 2025-10-16 | Viro-Gen (Pty) Ltd | Plasmid for expression of ksp37 |
| WO2025221871A1 (en) * | 2024-04-16 | 2025-10-23 | The Trustees Of Columbia University In The City Of New York | Expansion, propagation, and modulation of immune cell subsets by peptides |
| WO2025233868A1 (en) * | 2024-05-07 | 2025-11-13 | Viro-Gen (Pty) Ltd | Compounds, compositions and methods for treating, reversing or preventing cancer |
| WO2025233869A1 (en) * | 2024-05-07 | 2025-11-13 | Viro-Gen (Pty) Ltd | Compounds, compositions and methods for treating, reversing or preventing type 2 diabetes mellitus |
-
2021
- 2021-07-09 BR BR112022026874A patent/BR112022026874A2/pt unknown
- 2021-07-09 US US18/004,631 patent/US20240091310A1/en active Pending
- 2021-07-09 AU AU2021304479A patent/AU2021304479A1/en active Pending
- 2021-07-09 CN CN202180042656.8A patent/CN115720520A/zh active Pending
- 2021-07-09 PE PE2022003070A patent/PE20231554A1/es unknown
- 2021-07-09 MX MX2023000113A patent/MX2023000113A/es unknown
- 2021-07-09 CA CA3179965A patent/CA3179965A1/en active Pending
- 2021-07-09 WO PCT/IB2021/056179 patent/WO2022009165A1/en not_active Ceased
- 2021-07-09 PH PH1/2023/550038A patent/PH12023550038A1/en unknown
- 2021-07-09 JP JP2022575231A patent/JP2023533162A/ja active Pending
- 2021-07-09 EP EP21838245.5A patent/EP4178604A4/en active Pending
- 2021-07-09 KR KR1020237004448A patent/KR20230038230A/ko active Pending
- 2021-07-09 IL IL299661A patent/IL299661A/en unknown
-
2022
- 2022-12-09 ZA ZA2022/13371A patent/ZA202213371B/en unknown
- 2022-12-29 CO CONC2022/0019251A patent/CO2022019251A2/es unknown
-
2023
- 2023-01-06 CL CL2023000073A patent/CL2023000073A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023533162A5 (https=) | ||
| US6410570B1 (en) | Methods of inactivating a virus and controlling viral replication | |
| JP2024170583A5 (https=) | ||
| CN101595217A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的1H-咪唑并[4,5-c]喹啉-4-胺类及其相关化合物的前药 | |
| JP2023535744A5 (https=) | ||
| CN113304166A (zh) | 核苷类化合物在治疗冠状病毒感染性疾病中的用途 | |
| US11965006B2 (en) | Antimicrobial and anti-cancer therapy | |
| JP2002528502A5 (https=) | ||
| CA2690641A1 (en) | Early intervention of viral infections with immune activators | |
| TW202110461A (zh) | 流行性感冒病毒感染症或冠狀病毒感染症之預防及/或治療劑 | |
| JP2000517323A (ja) | Ｂ型肝炎およびレトロウイルス関連疾患の治療のためのジカフェオイルキナ酸の新規使用および新規カフェオイルキナ酸誘導体 | |
| AU781066B2 (en) | Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof | |
| JP2023528561A5 (https=) | ||
| JP2007504268A (ja) | ヘルペス感染症を処置するための方法および組成物 | |
| JP2007099747A (ja) | トリインフルエンザ感染の治療 | |
| WO2021053126A1 (en) | Method of treating hbv infection using a core protein allosteric modulator | |
| JP2024520567A (ja) | 肺線維症の予防または治療用の薬学製剤 | |
| RU2022132823A (ru) | Композиции и способы, пригодные для предупреждения и/или лечения заболевания у млекопитающих | |
| JP2023529025A5 (https=) | ||
| JP2022513438A5 (https=) | ||
| ES2968931T3 (es) | Efecto sinérgico de eyp001 e ifn-alfa pegilado para el tratamiento de la infección por hbv | |
| WO2021195185A1 (en) | Method of treating coronavirus infection by administration of ethyl mercury or thiol derivative thereof | |
| WO2021202990A2 (en) | Methods for the treatment of betacoronavirus infections | |
| JPH02172920A (ja) | 抗潰瘍剤 | |
| CN113940933A (zh) | 抗新型冠状病毒的药物 |